ArticleHepatology (Baltimore, Md.)2009

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Tania Mara Welzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.